Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains

While individuals infected with coronavirus disease 2019 (COVID-19) manifested a broad range in susceptibility and severity to the disease, the pre-existing immune memory to related pathogens cross-reactive against SARS-CoV-2 can influence the disease outcome in COVID-19. Here, we investigated the p...

Full description

Bibliographic Details
Main Authors: Lee, CH, Pinho, MP, Buckley, PR, Woodhouse, IB, Ogg, G, Simmons, A, Napolitani, G, Koohy, H
Format: Journal article
Language:English
Published: Frontiers Media 2020
_version_ 1826259715816947712
author Lee, CH
Pinho, MP
Buckley, PR
Woodhouse, IB
Ogg, G
Simmons, A
Napolitani, G
Koohy, H
author_facet Lee, CH
Pinho, MP
Buckley, PR
Woodhouse, IB
Ogg, G
Simmons, A
Napolitani, G
Koohy, H
author_sort Lee, CH
collection OXFORD
description While individuals infected with coronavirus disease 2019 (COVID-19) manifested a broad range in susceptibility and severity to the disease, the pre-existing immune memory to related pathogens cross-reactive against SARS-CoV-2 can influence the disease outcome in COVID-19. Here, we investigated the potential extent of T cell cross-reactivity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be conferred by other coronaviruses and influenza virus, and generated an in silico map of public and private CD8+ T cell epitopes between coronaviruses. We observed 794 predicted SARS-CoV-2 epitopes of which 52% were private and 48% were public. Ninety-nine percent of the public epitopes were shared with SARS-CoV and 5.4% were shared with either one of four common coronaviruses, 229E, HKU1, NL63, and OC43. Moreover, to assess the potential risk of self-reactivity and/or diminished T cell response for peptides identical or highly similar to the host, we identified predicted epitopes with high sequence similarity with human proteome. Lastly, we compared predicted epitopes from coronaviruses with epitopes from influenza virus deposited in IEDB, and found only a small number of peptides with limited potential for cross-reactivity between the two virus families. We believe our comprehensive in silico profile of private and public epitopes across coronaviruses would facilitate design of vaccines, and provide insights into the presence of pre-existing coronavirus-specific memory CD8+ T cells that may influence immune responses against SARS-CoV-2.
first_indexed 2024-03-06T18:54:11Z
format Journal article
id oxford-uuid:113f56a7-5e23-4975-b293-b633f9053e83
institution University of Oxford
language English
last_indexed 2024-03-06T18:54:11Z
publishDate 2020
publisher Frontiers Media
record_format dspace
spelling oxford-uuid:113f56a7-5e23-4975-b293-b633f9053e832022-03-26T10:01:19ZPotential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strainsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:113f56a7-5e23-4975-b293-b633f9053e83EnglishSymplectic ElementsFrontiers Media 2020Lee, CHPinho, MPBuckley, PRWoodhouse, IBOgg, GSimmons, ANapolitani, GKoohy, HWhile individuals infected with coronavirus disease 2019 (COVID-19) manifested a broad range in susceptibility and severity to the disease, the pre-existing immune memory to related pathogens cross-reactive against SARS-CoV-2 can influence the disease outcome in COVID-19. Here, we investigated the potential extent of T cell cross-reactivity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be conferred by other coronaviruses and influenza virus, and generated an in silico map of public and private CD8+ T cell epitopes between coronaviruses. We observed 794 predicted SARS-CoV-2 epitopes of which 52% were private and 48% were public. Ninety-nine percent of the public epitopes were shared with SARS-CoV and 5.4% were shared with either one of four common coronaviruses, 229E, HKU1, NL63, and OC43. Moreover, to assess the potential risk of self-reactivity and/or diminished T cell response for peptides identical or highly similar to the host, we identified predicted epitopes with high sequence similarity with human proteome. Lastly, we compared predicted epitopes from coronaviruses with epitopes from influenza virus deposited in IEDB, and found only a small number of peptides with limited potential for cross-reactivity between the two virus families. We believe our comprehensive in silico profile of private and public epitopes across coronaviruses would facilitate design of vaccines, and provide insights into the presence of pre-existing coronavirus-specific memory CD8+ T cells that may influence immune responses against SARS-CoV-2.
spellingShingle Lee, CH
Pinho, MP
Buckley, PR
Woodhouse, IB
Ogg, G
Simmons, A
Napolitani, G
Koohy, H
Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains
title Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains
title_full Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains
title_fullStr Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains
title_full_unstemmed Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains
title_short Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains
title_sort potential cd8 t cell cross reactivity against sars cov 2 conferred by other coronavirus strains
work_keys_str_mv AT leech potentialcd8tcellcrossreactivityagainstsarscov2conferredbyothercoronavirusstrains
AT pinhomp potentialcd8tcellcrossreactivityagainstsarscov2conferredbyothercoronavirusstrains
AT buckleypr potentialcd8tcellcrossreactivityagainstsarscov2conferredbyothercoronavirusstrains
AT woodhouseib potentialcd8tcellcrossreactivityagainstsarscov2conferredbyothercoronavirusstrains
AT oggg potentialcd8tcellcrossreactivityagainstsarscov2conferredbyothercoronavirusstrains
AT simmonsa potentialcd8tcellcrossreactivityagainstsarscov2conferredbyothercoronavirusstrains
AT napolitanig potentialcd8tcellcrossreactivityagainstsarscov2conferredbyothercoronavirusstrains
AT koohyh potentialcd8tcellcrossreactivityagainstsarscov2conferredbyothercoronavirusstrains